BDI Posts Record Sales Revenue

COLUMBIA, SC--(Marketwire - January 08, 2009) -

Highlighted Links

www.ivig.com

BDI, a national leader in the distribution of biopharmaceutical products, announced that final figures for fiscal year 2008 indicated an increase in Sales Revenue by twenty eight percent (28%) in comparison to those posted in fiscal year 2007. "This rate of growth surpassed the company's expectations for 2008 and marks six consecutive fiscal years of double-digit increases in Sales Revenue. Such results are indicative of the professionalism, integrity and sincerity of service which BDI has offered to the healthcare community for the past fourteen years," stated Eddie Stiefel, Jr., Co-President of BDI.

"The true measure of the company's success is that BDI's growth is represented across all product lines," said Richard J. Gaton, Co-President. "This exemplifies our commitment to servicing the varied needs of healthcare providers and providing measurable value for manufacturing trade partners. We believe it has truly been a winning combination for all involved."

About BDI

Serving the healthcare community since 1995, BDI (Blood Diagnostics, Inc.), the preeminent national wholesaler of specialty biopharmaceutical products, has built an outstanding reputation as an industry source for products and service. BDI's market focus is evident in its commitment to specialty biotherapeutics, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a recognized Authorized Distributor of Record for the products it supplies from distribution centers located on both the East and West coast, BDI services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI defines its customer-centric approach to serving the nation's healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI's educational literature and web site -- www.ivig.com -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.